Haringman JJ - Search Results

1

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, Loetscher P, Schmouder R, Woodworth T, Tak PP. Haringman JJ, et al. Arthritis Rheum. 2006 Aug;54(8):2387-92. doi: 10.1002/art.21975. Arthritis Rheum. 2006. PMID: 16869001 Free article. Clinical Trial.

2

Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis.

Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP. Kraan MC, et al. Among authors: haringman jj. Rheumatology (Oxford). 1999 Nov;38(11):1074-80. doi: 10.1093/rheumatology/38.11.1074. Rheumatology (Oxford). 1999. PMID: 10556258

3

Quantification of the cell infiltrate in synovial tissue by digital image analysis.

Kraan MC, Haringman JJ, Ahern MJ, Breedveld FC, Smith MD, Tak PP. Kraan MC, et al. Among authors: haringman jj. Rheumatology (Oxford). 2000 Jan;39(1):43-9. doi: 10.1093/rheumatology/39.1.43. Rheumatology (Oxford). 2000. PMID: 10662872

4

The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8).

Kraan MC, Patel DD, Haringman JJ, Smith MD, Weedon H, Ahern MJ, Breedveld FC, Tak PP. Kraan MC, et al. Among authors: haringman jj. Arthritis Res. 2001;3(1):65-71. doi: 10.1186/ar141. Epub 2000 Nov 9. Arthritis Res. 2001. PMID: 11178128 Free PMC article.

5

Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.

Haringman JJ, Kraan MC, Smeets TJ, Zwinderman KH, Tak PP. Haringman JJ, et al. Ann Rheum Dis. 2003 Aug;62(8):715-21. doi: 10.1136/ard.62.8.715. Ann Rheum Dis. 2003. PMID: 12860725 Free PMC article. Clinical Trial.

6

Chemokines in joint disease: the key to inflammation?

Haringman JJ, Ludikhuize J, Tak PP. Haringman JJ, et al. Ann Rheum Dis. 2004 Oct;63(10):1186-94. doi: 10.1136/ard.2004.020529. Epub 2004 Apr 13. Ann Rheum Dis. 2004. PMID: 15082471 Free PMC article. Review.

7

T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis.

Kraan MC, Haringman JJ, Weedon H, Barg EC, Smith MD, Ahern MJ, Smeets TJ, Breedveld FC, Tak PP. Kraan MC, et al. Among authors: haringman jj. Ann Rheum Dis. 2004 May;63(5):483-8. doi: 10.1136/ard.2003.009225. Ann Rheum Dis. 2004. PMID: 15082476 Free PMC article.

8

Chemokine blockade: a new era in the treatment of rheumatoid arthritis?

Haringman JJ, Tak PP. Haringman JJ, et al. Arthritis Res Ther. 2004;6(3):93-7. doi: 10.1186/ar1172. Epub 2004 Apr 1. Arthritis Res Ther. 2004. PMID: 15142257 Free PMC article. Review.

9

[Blockade of chemokines in chronic inflammatory diseases].

Haringman JJ, Tak PP. Haringman JJ, et al. Ned Tijdschr Geneeskd. 2004 Sep 4;148(36):1760-4. Ned Tijdschr Geneeskd. 2004. PMID: 15495938 Review. Dutch.

10

Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP. Haringman JJ, et al. Ann Rheum Dis. 2005 Jun;64(6):834-8. doi: 10.1136/ard.2004.029751. Epub 2004 Dec 2. Ann Rheum Dis. 2005. PMID: 15576415 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters